Lapatinib

Lapatinib · Teva Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

151 regulatory and trial events tracked for Lapatinib, covering 2008-07-30 to 2025-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder [Phase 2]